Fig. 5From: Optimizing labelling conditions of 213Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapyTime-integrated activity of 213Bi, 213Po, 209Tl and 209Pb determined by Bateman equations a and the resultant total absorbed dose rate b as a function of time, see Table 2. The majority of the absorbed dose rate (96 % at 60 min) is caused by the α-particles from 213Bi and 213PoBack to article page